Fenretinide Targets Chronic Myeloid Leukemia Stem/Progenitor Cells by Regulation of Redox Signaling-Reference-Cited by-同舟云学术

Fenretinide Targets Chronic Myeloid Leukemia Stem/Progenitor Cells by Regulation of Redox Signaling

Published:2014-04-20 Issue:12 Volume:20 Page:1866-1880
ISSN:1523-0864
Container-title:Antioxidants & Redox Signaling
language:en
Short-container-title:Antioxidants & Redox Signaling

Author:

Du Yanzhi¹,Xia Yuan¹²,Pan Xiaoling¹²,Chen Zi³,Wang Aihua⁴,Wang Kankan⁴,Li Junmin⁴,Zhang Ji¹⁴⁵

Affiliation:

1. Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences (SIBS), Chinese Academy of Sciences (CAS), Shanghai Jiao Tong University School of Medicine (SJTU-SM), Shanghai, China.

2. Graduate School of the Chinese Academy of Sciences, Shanghai, China.

3. Huashan Hospital Affiliated to Fudan University, Shanghai, China.

4. State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, SJTU-SM, Shanghai, China.

5. Laboratory of Translational Research (LTR), Sino-French Research Center for Life Sciences and Genomics, Ruijin Hospital, SJTU-SM, Shanghai, China.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry,Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry

Link

http://www.liebertpub.com/doi/pdf/10.1089/ars.2012.4935

Reference60 articles.

1. The Gene Ontology project in 2008

2. Molecules in focus The NF-E2 transcription factor

3. Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment

4. Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor

5. Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nano-fenretinide demonstrates remarkable activity in acute promyeloid leukemia cells;Scientific Reports;2024-06-14

2. Fenretinide combines perturbation of signaling kinases, cell–extracellular matrix interactions and matrix metalloproteinase activation to inhibit invasion in oral squamous cell carcinoma cells;Carcinogenesis;2022-08-17

3. Targeting Sphingolipids for Cancer Therapy;Frontiers in Oncology;2021-10-19

4. The unfolding role of ceramide in coordinating retinoid-based cancer therapy;Biochemical Journal;2021-10-14

5. Targeting Leukemic Stem Cells in Chronic Myeloid Leukemia: Is It Worth the Effort?;International Journal of Molecular Sciences;2021-06-30